{"DataElement":{"publicId":"5105880","version":"1","preferredName":"Laboratory Procedure Creatine Kinase Clinical Trial Eligibility Criteria Yes No Exception Code Indicator","preferredDefinition":"The coded yes/no/exception indicator whether a medical procedure has been performed that involves testing a sample of blood to test creatine kinase.","longName":"LAB_PROC_CK_Y_N_EX_CD_IND","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"5071335","version":"1","preferredName":"Laboratory Procedure Creatine Kinase Clinical Trial Eligibility Criteria","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._An enzyme complex that can reversibly convert ATP and creatine to phosphocreatine and ADP. Cytosolic creatine kinases are comprised of homodimers or heterodimers of creatine kinase B-type protein and creatine kinase M-type protein. Mitochondrial creatine kinases are octomers comprised of either four homodimers of creatine kinase U-type, mitochondrial protein or four creatine kinase S-type, mitochondrial protein homodimers._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","longName":"2543047v1.0:5071333v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"2543047","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2262D258-9F2F-4D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5071333","version":"1","preferredName":"Creatine Kinase Clinical Trial Eligibility Criteria","preferredDefinition":"An enzyme complex that can reversibly convert ATP and creatine to phosphocreatine and ADP. Cytosolic creatine kinases are comprised of homodimers or heterodimers of creatine kinase B-type protein and creatine kinase M-type protein. Mitochondrial creatine kinases are octomers comprised of either four homodimers of creatine kinase U-type, mitochondrial protein or four creatine kinase S-type, mitochondrial protein homodimers.:Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","longName":"C113245:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Creatine Kinase","conceptCode":"C113245","definition":"An enzyme complex that can reversibly convert ATP and creatine to phosphocreatine and ADP. Cytosolic creatine kinases are comprised of homodimers or heterodimers of creatine kinase B-type protein and creatine kinase M-type protein. Mitochondrial creatine kinases are octomers comprised of either four homodimers of creatine kinase U-type, mitochondrial protein or four creatine kinase S-type, mitochondrial protein homodimers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"26076773-A1A7-0E10-E050-BB89AD436499","latestVersionIndicator":"Yes","beginDate":"2015-12-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2015-12-03","modifiedBy":"ONEDATA","dateModified":"2015-12-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"26076773-A1B8-0E10-E050-BB89AD436499","latestVersionIndicator":"Yes","beginDate":"2015-12-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2015-12-03","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Curated for Protocol CITN-12. bsm","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5105852","version":"1","preferredName":"Yes No Exception Code Indicator","preferredDefinition":"Indicator to represent a response of Yes, No, or Exception._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data._An instance that does not conform to a rule or generalization._A symbol or combination of symbols which is assigned to the members of a collection.","longName":"YES_NO_NA_EXPTN_CD_IND","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"X","valueDescription":"Exception","ValueMeaning":{"publicId":"5105853","version":"1","preferredName":"Exception","longName":"5105853","preferredDefinition":"An instance that does not conform to a rule or generalization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Exception","conceptCode":"C54420","definition":"An instance that does not conform to a rule or generalization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"29CB2EB2-B418-F361-E050-BB89AD430775","latestVersionIndicator":"Yes","beginDate":"2016-01-20","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-01-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"29CB2EB2-B431-F361-E050-BB89AD430775","beginDate":"2016-01-20","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-01-20","modifiedBy":"ONEDATA","dateModified":"2016-01-20","deletedIndicator":"No"},{"value":"N","valueDescription":"No","ValueMeaning":{"publicId":"2559515","version":"1","preferredName":"No","longName":"2559515","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B588-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2024-01-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"29CB2EB2-B43B-F361-E050-BB89AD430775","beginDate":"2002-08-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-01-20","modifiedBy":"ONEDATA","dateModified":"2016-01-20","deletedIndicator":"No"},{"value":"Y","valueDescription":"Yes","ValueMeaning":{"publicId":"2560453","version":"1","preferredName":"Yes","longName":"2560453","preferredDefinition":"The affirmative response to a question or activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B932-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CLOHNES","dateModified":"2023-09-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"29CB2EB2-B445-F361-E050-BB89AD430775","beginDate":"2002-08-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-01-20","modifiedBy":"ONEDATA","dateModified":"2016-01-20","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5105851","version":"1","preferredName":"Yes No Exception Code Indicator","preferredDefinition":"The affirmative response to a question.:The non-affirmative response to a question.:An instance that does not conform to a rule or generalization.:A symbol or combination of symbols which is assigned to the members of a collection.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"5105851v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Exception","conceptCode":"C54420","definition":"An instance that does not conform to a rule or generalization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"29CB2EB2-B3EF-F361-E050-BB89AD430775","latestVersionIndicator":"Yes","beginDate":"2016-01-20","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-01-20","modifiedBy":"ONEDATA","dateModified":"2016-01-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CTMS:Clinical Trials Monitoring Service","workflowStatus":"RELEASED","registrationStatus":"Application","id":"29CB2EB2-B400-F361-E050-BB89AD430775","latestVersionIndicator":"Yes","beginDate":"2016-01-20","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-01-20","modifiedBy":"MAESKEB","dateModified":"2016-01-20","changeDescription":"Created to support Theradex design of CRFs. bsm","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"3876352","version":"1","longName":"Inclusion Criteria","context":"Theradex","ClassificationSchemeItems":[{"publicId":"3876425","version":"1","longName":"Laboratory Data (including serologic/viral status)","context":"Theradex"}]}],"AlternateNames":[{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"Is pre-study creatine kinase","type":"Preferred Question Text","description":"Is pre-study creatine kinase less than 5 x institutional upper limit of normal?","url":null,"context":"Theradex"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Does patient have CTCAE V. 5.0 Grade 3 symptomatic CPK elevation (more than 5 times the upper limit of normal)?","url":null,"context":"COG"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"29CBBF66-9BA3-E0CF-E050-BB89AD43442E","latestVersionIndicator":"Yes","beginDate":"2016-01-20","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-01-20","modifiedBy":"GALITG","dateModified":"2022-04-18","changeDescription":"Curated for Protocol CITN-12. bsm","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}